45,784 Shares in Solventum Co. (NYSE:SOLV) Acquired by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. purchased a new position in shares of Solventum Co. (NYSE:SOLV) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 45,784 shares of the company’s stock, valued at approximately $3,029,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of SOLV. Quantinno Capital Management LP acquired a new stake in shares of Solventum in the third quarter worth $448,000. Kovitz Investment Group Partners LLC purchased a new position in shares of Solventum in the third quarter valued at $356,000. EP Wealth Advisors LLC purchased a new position in shares of Solventum in the third quarter valued at $355,000. XTX Topco Ltd purchased a new position in shares of Solventum in the third quarter valued at $416,000. Finally, Orion Portfolio Solutions LLC purchased a new position in shares of Solventum in the third quarter valued at $1,316,000.

Analyst Ratings Changes

Several brokerages have recently weighed in on SOLV. Wells Fargo & Company upped their target price on shares of Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Bank of America upped their target price on shares of Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research note on Wednesday, February 26th. Mizuho increased their price objective on shares of Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd. Piper Sandler increased their price objective on shares of Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a research note on Friday, February 28th. Finally, The Goldman Sachs Group increased their price objective on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a research note on Monday, March 3rd. One analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $79.86.

Solventum Price Performance

NYSE SOLV opened at $68.61 on Thursday. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The stock has a market capitalization of $11.87 billion and a PE ratio of 24.95. The company has a 50 day moving average price of $74.52 and a two-hundred day moving average price of $71.75. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $85.92.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.